These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Partial inhibition of the early and late asthmatic response by a single dose of salmeterol. Weersink EJ; Aalbers R; Koëter GH; Kauffman HF; De Monchy JG; Postma DS Am J Respir Crit Care Med; 1994 Nov; 150(5 Pt 1):1262-7. PubMed ID: 7952550 [TBL] [Abstract][Full Text] [Related]
43. Effect of interleukin 13 on bronchial hyperresponsiveness and the bronchoprotective effect of beta-adrenergic bronchodilators and corticosteroids. Townley RG; Gendapodi PR; Qutna N; Evans J; Romero FA; Abel P Ann Allergy Asthma Immunol; 2009 Mar; 102(3):190-7. PubMed ID: 19354064 [TBL] [Abstract][Full Text] [Related]
44. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853 [TBL] [Abstract][Full Text] [Related]
45. Effects of local treatment with salmeterol and terbutaline on anti-IgE-induced wheal, flare, and late induration in human skin. Grönneberg R; Raud J Allergy; 1996 Oct; 51(10):685-92. PubMed ID: 8904995 [TBL] [Abstract][Full Text] [Related]
46. Comparison of duration of agonist action at beta 1- and beta 2- adrenoceptors in C6 glioma cells: evidence that the long duration of action of salmeterol is specific to the beta 2-adrenoceptor. McCrea KE; Hill SJ Mol Pharmacol; 1996 May; 49(5):927-37. PubMed ID: 8622643 [TBL] [Abstract][Full Text] [Related]
47. The role of the leukocyte adhesion molecules VLA-4, LFA-1, and Mac-1 in allergic airway responses in the rat. Rabb HA; Olivenstein R; Issekutz TB; Renzi PM; Martin JG Am J Respir Crit Care Med; 1994 May; 149(5):1186-91. PubMed ID: 8173758 [TBL] [Abstract][Full Text] [Related]
48. Salmeterol attenuates chemotactic responses in rhinovirus-induced exacerbation of allergic airways disease by modulating protein phosphatase 2A. Hatchwell L; Girkin J; Dun MD; Morten M; Verrills N; Toop HD; Morris JC; Johnston SL; Foster PS; Collison A; Mattes J J Allergy Clin Immunol; 2014 Jun; 133(6):1720-7. PubMed ID: 24388637 [TBL] [Abstract][Full Text] [Related]
49. Long- and short-acting beta2 adrenoceptor agonists: interactions in human contracted bronchi. Molimard M; Naline E; Zhang Y; Le Gros V; Begaud B; Advenier C Eur Respir J; 1998 Mar; 11(3):583-8. PubMed ID: 9596106 [TBL] [Abstract][Full Text] [Related]
50. Probing the salmeterol binding site on the beta 2-adrenergic receptor using a novel photoaffinity ligand, [(125)I]iodoazidosalmeterol. Rong Y; Arbabian M; Thiriot DS; Seibold A; Clark RB; Ruoho AE Biochemistry; 1999 Aug; 38(35):11278-86. PubMed ID: 10471277 [TBL] [Abstract][Full Text] [Related]
51. Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Maris NA; de Vos AF; Dessing MC; Spek CA; Lutter R; Jansen HM; van der Zee JS; Bresser P; van der Poll T Am J Respir Crit Care Med; 2005 Oct; 172(7):878-84. PubMed ID: 15994467 [TBL] [Abstract][Full Text] [Related]
52. Inhibition by viozan of extravasation induced in rat trachea by capsaicin is mediated exclusively by beta 2-adrenoceptors. Fozard JR; Baur F; Wolber C; Collingwood SP Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):570-2. PubMed ID: 11770013 [TBL] [Abstract][Full Text] [Related]
53. Characterization of tolerance to the anti-leakage effect of formoterol in rat airways. Bowden JJ; Anderson GP; Lefevre PM; Sulakvelidze I; McDonald DM Eur J Pharmacol; 1997 Oct; 338(1):83-7. PubMed ID: 9408007 [TBL] [Abstract][Full Text] [Related]
54. The effects of formoterol on plasma exudation produced by a localized acute inflammatory response to bradykinin in the tracheal mucosa of rats in vivo. O'Donnell SR; Anderson GP Br J Pharmacol; 1995 Sep; 116(1):1571-6. PubMed ID: 8564220 [TBL] [Abstract][Full Text] [Related]
55. On the mechanism of the persistent action of salmeterol: what is the current position? Coleman RA Br J Pharmacol; 2009 Sep; 158(1):180-2. PubMed ID: 19719780 [TBL] [Abstract][Full Text] [Related]
56. The beta 2-adrenergic receptor agonist formoterol reduces microvascular leakage by inhibiting endothelial gap formation. Baluk P; McDonald DM Am J Physiol; 1994 Apr; 266(4 Pt 1):L461-8. PubMed ID: 7513964 [TBL] [Abstract][Full Text] [Related]
57. Activation of beta 2-adrenergic receptors and ventricular fibrillation. Billman GE; Altschuld RA Cardiologia; 1998 Aug; 43(8):811-8. PubMed ID: 9808871 [No Abstract] [Full Text] [Related]
58. Effects of β-adrenergic receptor agonists on drinking and arterial blood pressure in young and old rats. Thunhorst RL; Grobe CL; Beltz TG; Johnson AK Am J Physiol Regul Integr Comp Physiol; 2011 Apr; 300(4):R1001-8. PubMed ID: 21307363 [TBL] [Abstract][Full Text] [Related]
59. Inhibition of tracheal vascular extravasation by liposome-encapsulated albuterol in rats. Zhang W; Guo L; Nadel JA; Papahadjopoulos D Pharm Res; 1998 Mar; 15(3):455-60. PubMed ID: 9563077 [TBL] [Abstract][Full Text] [Related]
60. An in vitro rat diaphragmatic fatigue model induced by combined hypoxic and hypercapnic acidosis and the effect of salmeterol. Xu X; Zhou J; Yang Q; Fang L; Xie Q; Shen Y Pharmacol Res; 2006 Feb; 53(2):171-6. PubMed ID: 16310375 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]